C07K 14/695
Corticotropin [acth]
Official title: Corticotropin [ACTH]
C07K14/695 (Corticotropin [acth]) appears on 79 US grants and 47 published applications in this corpus.
Search patents in C07K- Granted patents
- 79
- Published applications
- 47
- Assignees
- 54
- Inventors
- 153
- Latest grant
- 14 Oct 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 3 | 0 |
| 1978 | 5 | 0 |
| 1979 | 0 | 0 |
| 1980 | 2 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 2 | 0 |
| 1984 | 3 | 0 |
| 1985 | 2 | 0 |
| 1986 | 2 | 0 |
| 1987 | 1 | 0 |
| 1988 | 2 | 0 |
| 1989 | 2 | 0 |
| 1990 | 2 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 4 | 0 |
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 3 |
| 2004 | 2 | 3 |
| 2005 | 1 | 0 |
| 2006 | 0 | 4 |
| 2007 | 1 | 3 |
| 2008 | 2 | 7 |
| 2009 | 0 | 2 |
| 2010 | 2 | 1 |
| 2011 | 4 | 3 |
| 2012 | 0 | 2 |
| 2013 | 3 | 0 |
| 2014 | 3 | 4 |
| 2015 | 1 | 0 |
| 2016 | 1 | 2 |
| 2017 | 2 | 1 |
| 2018 | 0 | 0 |
| 2019 | 1 | 3 |
| 2020 | 0 | 0 |
| 2021 | 1 | 1 |
| 2022 | 2 | 5 |
| 2023 | 1 | 0 |
| 2024 | 2 | 2 |
| 2025 | 3 | 0 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Amino diacids containing peptide modifiers14 Oct 2025US 12,441,760 B2Chemical & Biopharmaceutical Laboratories of Patras S.A.
- Targeting of melanocytes for delivering therapeutic or diagnostic agents using protein nanocages20 May 2025US 12,303,555 B2Nanyang Technological University
- Method for screening protease variant and obtained protease variant8 Apr 2025US 12,270,124 B2Shangrao Concord Pharmaceutical Co., Ltd.
- Radiolabeled melanocortin 1 receptor-specific alpha-melanocyte-stimulating hormone analogues for imaging or therapy28 May 2024US 11,992,537 B2Provincial Health Services Authority
- TEV protease variant, fusion protein thereof, preparation method therefor and use thereof5 Mar 2024US 11,919,936 B2Shangrao Concord Pharmaceutical Co., Ltd.
- Radiolabeled melanocortin 1 receptor-specific alpha-melanocyte-stimulating hormone analogues for imaging or therapy24 Oct 2024US 2024/0350681 A1Provincial Health Services Authority
- Amino diacids containing peptide modifiers4 Jan 2024US 2024/0002433 A1Chemical & Biopharmaceutical Laboratories of Patras S.A.
- Targeting of melanocytes for delivering therapeutic or diagnostic agents using protein nanocages3 Mar 2022US 2022/0062387 A1Nanyang Technological University
- Formulation Including a Combination of beta-Endorphin and Adrenocorticotropic Hormone24 Feb 2022US 2022/0054595 A1Adamis Pharmaceuticals Corporation
- Tev protease variant, fusion protein thereof, preparation method therefor and use thereof24 Feb 2022US 2022/0056099 A1Shangrao Concord Pharmaceutical Co., Ltd.
Most cited
By later US patents
- Chimeric peptides for neuropeptide delivery through the blood-brain barrier238US 4,801,575 AThe Regents of the University of California · 1989
- Chimeric peptides for neuropeptide delivery through the blood-brain barrier215US 4,902,505 AAlkermes, Inc. · 1990
- Modified peptide derivatives conjugated at 2-hydroxyethylamine moieties153US 5,362,852 APfizer Inc. · 1994
- Preparation of protein microparticles by supercritical fluid precipitation132US 6,063,910 AThe Trustees of Princeton University · 2000
- E. coli/Saccharomyces cerevisiae plasmid cloning vector containing the alpha-factor gene for secretion and processing of hybrid proteins111US 4,546,082 AThe Regents of the Univ. of California · 1985